Mr. Bartekian is President of Vantage BioTrials, an award-winning Canadian CRO specialized in clinical trial management services. He's contributed his strong drug development knowledge to the pharma, device and clinical research industry for over 22 years and has gained vast experience handling complicated trials across an array of therapeutic areas. Mr. Bartekian also contributes his knowledge as an Advisor to Global Affairs Canada’s Life Science division, and Colorectal Cancer Canada’s Scientific Advisory Board for the establishment of a Patient Group Pathway Model to Accessing Cancer Clinical Trials. Over the years, Vantage BioTrials has won several peer-recognition awards, such as “Emerging Pharma Leader 2011” by PharmaExec Magazine, “Life Science Entrepreneur of the Year 2015” by Ernst & Young, “Biotechnology CRO of the Year 2018” by Global Health & Pharma, “Most Valuable Clinical/Access Initiative Finalist 2019” by EyeForPharma, and “Canada’s Leading Clinical Research & Trial Management Organization 2020” by AI Magazine.